Evidence map›Paper›PMID 42734738›Full record

ArticleInfection2026

A machine learning approach for differential classification of chikungunya virus: an explainable AI study based on surveillance data.

Natacha Usanase, Berna Uzun, Dilber Uzun Ozsahin

Abstract read
PubMed Publisher
In one paragraph

Article in Infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natacha UsanaseIrfan Suat Gunsel Operational Research Institute, Near East University, Mersin 10, Nicosia, TRNC, Turkey. natacha.usanase@neu.edu.tr.ORCID https://orcid.org/0000-0002-0901-4439
Berna UzunIrfan Suat Gunsel Operational Research Institute, Near East University, Mersin 10, Nicosia, TRNC, Turkey.
Dilber Uzun OzsahinIrfan Suat Gunsel Operational Research Institute, Near East University, Mersin 10, Nicosia, TRNC, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMosquito-borne viral diseases such as chikungunya usually present similar clinical symptoms, which makes them hard to differentiate without laboratory confirmatory tests. Therefore, this work retrospectively developed interpretable machine learning models to improve the classification of chikungunya using routinely collected data.

methodsBrazilian surveillance data, with 18,127 records, were analyzed, and eight different machine learning algorithms were trained and five-fold cross-validated. In addition, SHapley Additive exPlanations (SHAP) and permutation feature importance described model behavior.

resultsIn univariable analysis, arthralgia (OR = 5.84, 95% CI 5.39-6.33) and fever (OR = 5.85, 95% CI 5.29-6.46) were most positively associated with Chikungunya. The macro-AUC values ranged from 0.89 to 0.90 for all models in the multiclass analysis. The Chikungunya-versus-Non-Chikungunya task demonstrated moderate discrimination. The Chikungunya-versus-Dengue scenario produced the highest performance, with an AUC of 0.97 in most models.

conclusionThe explainability mechanism characterized how fitted models utilized available clinical and demographic predictors, with acute symptom variables contributing prominently to predictions. The results demonstrate the potential of using an interpretable model-assisted approach for arboviral classification. Importantly, prospective, temporal, and external geographic validation, with harmonized data, are required before clinical decision-support or point-of-care implementation can be considered.

Indexed as

Arboviral infectionDengueDiagnosisMachine learningOutbreaks

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.